Stock VRTX VERTEX PHARMACEUTICALS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-09 pm EDT 		Pre-market 08:24:05 am
419 USD +0.04% Intraday chart for Vertex Pharmaceuticals Incorporated 420 +0.24%
May. 07 FOMO is Back Our Logo
May. 07 ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins... Our Logo

ETFs positioned on Vertex Pharmaceuticals Incorporated

Name Weight AuM 1st Jan change Investor Rating
STERLING CAPITAL DIVERSE MULTI-MANAGER ACTIVE ETF- USD ETF Sterling Capital Diverse Multi-Manager Active ETF- USD
0.50% 92 M€ +0.06% -
AMUNDI MSCI USA ESG LEADERS SELECT UCITS ETF DR (C) - EUR HEDGED ETF Amundi MSCI USA ESG Leaders Select UCITS ETF DR (C) - EUR Hedged
0.48% 219 M€ +17.17% -
AMUNDI MSCI USA ESG LEADERS SELECT - UCITS ETF DR (C) - USD ETF AMUNDI MSCI USA ESG LEADERS SELECT - UCITS ETF DR (C) - USD
0.48% 1,448 M€ -.--% -
LYXOR MSCI USA ESG LEADERS EXTRA (DR) UCITS ETF - ACC - USD ETF Lyxor MSCI USA ESG Leaders Extra (DR) UCITS ETF - Acc - USD
0.47% 330 M€ -.--% -
LYXOR MSCI USA CLIMATE CHANGE UCITS ETF - USD ETF Lyxor MSCI USA Climate Change UCITS ETF - USD
0.44% 36 M€ +22.19%
HARTFORD LONGEVITY ECONOMY ETF - USD ETF Hartford Longevity Economy ETF - USD
0.42% 0 M€ +8.31%
VANECK MULTI-ASSET GROWTH ALLOCATION UCITS ETF - EUR ETF VanEck Multi-Asset Growth Allocation UCITS ETF - EUR
0.38% 0 M€ +3.70% -
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - DIST - USD ETF Lyxor Net Zero 2050 S&P 500 Climate PAB (DR) UCITS ETF - Dist - USD
0.35% 1,174 M€ +23.54%
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - ACC - USD ETF Lyxor Net Zero 2050 S&P 500 Climate PAB (DR) UCITS ETF - Acc - USD
0.35% 655 M€ -.--% -
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - DAILY HEDGED TO EUR - ACC - HEDGED EUR ETF Lyxor Net Zero 2050 S&P 500 Climate PAB (DR) UCITS ETF - Daily Hedged to EUR - Acc - Hedged EUR
0.35% 273 M€ -.--%
HARTFORD MULTIFACTOR US EQUITY ETF - USD ETF Hartford Multifactor US Equity ETF - USD
0.35% 0 M€ +7.68%
NOMURA NEXT FUNDS NASDAQ-100 ETF - JPY ETF Nomura NEXT FUNDS NASDAQ-100 ETF - JPY
0.35% 0 M€ +18.09% -
AMUNDI MSCI WORLD ESG LEADERS SELECT - UCITS ETF DR (C) - USD ETF AMUNDI MSCI WORLD ESG LEADERS SELECT - UCITS ETF DR (C) - USD
0.34% 276 M€ +11.40% -
AMUNDI S&P 500 ESG UCITS ETF ACC - EUR ETF Amundi S&P 500 ESG UCITS ETF Acc - EUR
0.32% 1,848 M€ +18.39% -
AMUNDI S&P 500 ESG UCITS ETF EUR HEDGED ACC - EUR ETF Amundi S&P 500 ESG UCITS ETF EUR HEDGED Acc - EUR
0.32% 559 M€ +14.30% -
V-SHARES US LEADERSHIP DIVERSITY ETF - USD ETF V-Shares US Leadership Diversity ETF - USD
0.32% 1 M€ +0.04%
CSIF (IE) MSCI USA ESG LEADERS BLUE UCITS ETF - B - USD ETF CSIF (IE) MSCI USA ESG Leaders Blue UCITS ETF - B - USD
0.32% 0 M€ +12.99%
NEXT FUNDS S&P 500 ESG INDEX EXCHANGE TRADED FUND - JPY ETF NEXT FUNDS S&P 500 ESG Index Exchange Traded Fund - JPY
0.30% 0 M€ +18.44% -
GOLDMAN SACHS ACTIVEBETA US LARGE CAP EQUITY UCITS ETFC- USD ETF Goldman Sachs ActiveBeta US Large Cap Equity UCITS ETFc- USD
0.28% 0 M€ +9.11%
OSSIAM BLOOMBERG USA PAB UCITS ETF - 1A (EUR) - EUR ETF OSSIAM BLOOMBERG USA PAB UCITS ETF - 1A (EUR) - EUR
0.28% 0 M€ +8.70%
OSSIAM BLOOMBERG USA PAB UCITS ETF - 1A - EUR HEDGED ETF OSSIAM BLOOMBERG USA PAB UCITS ETF - 1A - EUR HEDGED
0.28% 0 M€ +4.60% -
ASYMMETRIC SMART ALPHA S&P 500 ETF - USD ETF ASYMmetric Smart Alpha S&P 500 ETF - USD
0.25% 1 M€ -.--%
VANECK MULTI-ASSET BALANCED ALLOCATION UCITS ETF - EUR ETF VanEck Multi-Asset Balanced Allocation UCITS ETF - EUR
0.25% 0 M€ +2.77% -
REVERE SECTOR OPPORTUNITY ETF - USD ETF Revere Sector Opportunity ETF - USD
0.23% 6 M€ +17.98% -
AGILITY SHARES MANAGED RISK ETF - USD ETF Agility Shares Managed Risk ETF - USD
0.23% 0 M€ +6.76% -
ADAPTIVE RH HEDGED MULTI-ASSET INCOME ETF - USD ETF Adaptive RH Hedged Multi-Asset Income ETF - USD
0.22% 0 M€ +3.88% -
HSBC MSCI USA UCITS ETF - USD ETF HSBC MSCI USA UCITS ETF - USD
0.22% 0 M€ +11.62% -
FIDELITY U.S. HIGH QUALITY CURRENCY NEUTRAL INDEX ETF - CAD ETF Fidelity U.S. High Quality Currency Neutral Index ETF - CAD
0.22% 0 M€ +6.12% -
12345

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
Biotechnology & Medical Research
Calendar
2024-05-15 - Annual General Meeting
Related indices
S&P 500
More about the company

Income Statement Evolution

More financial data

Ratings for Vertex Pharmaceuticals Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
419 USD
Average target price
462.1 USD
Spread / Average Target
+10.29%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+2.97% 108B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+10.21% 104B
ARGENX SE Stock argenx SE
+2.42% 22.33B
BIONTECH SE Stock BioNTech SE
-12.77% 22.19B
GENMAB A/S Stock Genmab A/S
-7.05% 18.69B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.36% 17.74B
BEIGENE, LTD. Stock BeiGene, Ltd.
-6.50% 17.64B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.00% 14.05B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+37.20% 12.51B
VIKING THERAPEUTICS, INC. Stock Viking Therapeutics, Inc.
+330.95% 8.84B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. VRTX Stock
  4. Funds and ETFs Vertex Pharmaceuticals Incorporated
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW